BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 15113441)

  • 1. Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes.
    Sigurdson AJ; Hauptmann M; Chatterjee N; Alexander BH; Doody MM; Rutter JL; Struewing JP
    BMC Cancer; 2004 Mar; 4():9. PubMed ID: 15113441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.
    Rutter JL; Smith AM; Dávila MR; Sigurdson AJ; Giusti RM; Pineda MA; Doody MM; Tucker MA; Greene MH; Zhang J; Struewing JP
    Hum Mutat; 2003 Aug; 22(2):121-8. PubMed ID: 12872252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic polymorphisms in base-excision repair pathway genes and risk of breast cancer.
    Zhang Y; Newcomb PA; Egan KM; Titus-Ernstoff L; Chanock S; Welch R; Brinton LA; Lissowska J; Bardin-Mikolajczak A; Peplonska B; Szeszenia-Dabrowska N; Zatonski W; Garcia-Closas M
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):353-8. PubMed ID: 16492928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives.
    Cao AY; Huang J; Hu Z; Li WF; Ma ZL; Tang LL; Zhang B; Su FX; Zhou J; Di GH; Shen KW; Wu J; Lu JS; Luo JM; Yuan WT; Shen ZZ; Huang W; Shao ZM
    Breast Cancer Res Treat; 2009 May; 115(1):51-5. PubMed ID: 18483852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-nucleotide polymorphisms in the p53 pathway genes modify cancer risk in BRCA1 and BRCA2 carriers of Jewish-Ashkenazi descent.
    Yarden RI; Friedman E; Metsuyanim S; Olender T; Ben-Asher E; Papa MZ
    Mol Carcinog; 2010 Jun; 49(6):545-55. PubMed ID: 20306497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms XRCC1-R399Q and XRCC3-T241M and the risk of breast cancer at the Ontario site of the Breast Cancer Family Registry.
    Figueiredo JC; Knight JA; Briollais L; Andrulis IL; Ozcelik H
    Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):583-91. PubMed ID: 15066923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA-repair genetic polymorphisms and breast cancer risk.
    Smith TR; Levine EA; Perrier ND; Miller MS; Freimanis RI; Lohman K; Case LD; Xu J; Mohrenweiser HW; Hu JJ
    Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1200-4. PubMed ID: 14652281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer susceptibility variants alter risks in familial disease.
    Latif A; Hadfield KD; Roberts SA; Shenton A; Lalloo F; Black GC; Howell A; Evans DG; Newman WG
    J Med Genet; 2010 Feb; 47(2):126-31. PubMed ID: 19617217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of genetic polymorphisms in base excision repair genes on the risk of breast cancer in a Korean population.
    Kim KY; Han W; Noh DY; Kang D; Kwack K
    Gene; 2013 Dec; 532(2):192-6. PubMed ID: 24076439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer.
    Shu XO; Cai Q; Gao YT; Wen W; Jin F; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1462-7. PubMed ID: 14693738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms in DNA repair gene XRCC1 and increased genetic susceptibility to breast cancer.
    Chacko P; Rajan B; Joseph T; Mathew BS; Pillai MR
    Breast Cancer Res Treat; 2005 Jan; 89(1):15-21. PubMed ID: 15666192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study of XRCC1 (X-ray cross-complementing group 1) polymorphisms and breast cancer risk.
    Patel AV; Calle EE; Pavluck AL; Feigelson HS; Thun MJ; Rodriguez C
    Breast Cancer Res; 2005; 7(6):R1168-73. PubMed ID: 16457697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer risk is not associated with polymorphic forms of xeroderma pigmentosum genes in a cohort of women from Washington County, Maryland.
    Jorgensen TJ; Visvanathan K; Ruczinski I; Thuita L; Hoffman S; Helzlsouer KJ
    Breast Cancer Res Treat; 2007 Jan; 101(1):65-71. PubMed ID: 16823510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada.
    Risch HA; McLaughlin JR; Cole DE; Rosen B; Bradley L; Fan I; Tang J; Li S; Zhang S; Shaw PA; Narod SA
    J Natl Cancer Inst; 2006 Dec; 98(23):1694-706. PubMed ID: 17148771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGFBP1 and IGFBP3 polymorphisms predict circulating IGFBP-3 levels among women from high-risk breast cancer families.
    Rosendahl AH; Hietala M; Henningson M; Olsson H; Jernström H
    Breast Cancer Res Treat; 2011 Jun; 127(3):785-94. PubMed ID: 21140206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms of the DNA repair genes XPD (Lys751Gln) and XRCC1 (Arg399Gln and Arg194Trp): relationship to breast cancer risk and familial predisposition to breast cancer.
    Brewster AM; Jorgensen TJ; Ruczinski I; Huang HY; Hoffman S; Thuita L; Newschaffer C; Lunn RM; Bell D; Helzlsouer KJ
    Breast Cancer Res Treat; 2006 Jan; 95(1):73-80. PubMed ID: 16319991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers.
    Kadouri L; Easton DF; Edwards S; Hubert A; Kote-Jarai Z; Glaser B; Durocher F; Abeliovich D; Peretz T; Eeles RA
    Br J Cancer; 2001 Jul; 85(1):36-40. PubMed ID: 11437399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphisms in the DNA repair genes XRCC1, XRCC2 and XRCC3 and risk of breast cancer in Cyprus.
    Loizidou MA; Michael T; Neuhausen SL; Newbold RF; Marcou Y; Kakouri E; Daniel M; Papadopoulos P; Malas S; Kyriacou K; Hadjisavvas A
    Breast Cancer Res Treat; 2008 Dec; 112(3):575-9. PubMed ID: 18188695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease family history and modification of breast cancer risk in common BRCA2 variants.
    Seymour IJ; Casadei S; Zampiga V; Rosato S; Danesi R; Falcini F; Strada M; Morini N; Naldoni C; Paradiso A; Tommasi S; Schittulli F; Amadori D; Calistri D
    Oncol Rep; 2008 Mar; 19(3):783-6. PubMed ID: 18288416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common BRCA2 variants and modification of breast and ovarian cancer risk in BRCA1 mutation carriers.
    Hughes DJ; Ginolhac SM; Coupier I; Corbex M; Bressac-de-Paillerets B; Chompret A; Bignon YJ; Uhrhammer N; Lasset C; Giraud S; Hardouin A; Berthet P; Peyrat JP; Fournier J; Nogues C; Lidereau R; Muller D; Fricker JP; Longy M; Toulas C; Guimbaud R; Maugard C; Olschwang S; Yannoukakos D; Durocher F; Moisan AM; Simard J; Mazoyer S; Lynch HT; Szabo C; Lenoir GM; Goldgar DE; Stoppa-Lyonnet D; Sinilnikova OM
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):265-7. PubMed ID: 15668505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.